These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Nystad TW; Myrmel H J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan. Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024 [TBL] [Abstract][Full Text] [Related]
4. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients. Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658 [TBL] [Abstract][Full Text] [Related]
5. Antibodies to Epstein-Barr virus in neurological diseases. Gotlieb-Stematsky T; Arlazoroff A J Neurol Sci; 1976 May; 28(1):115-20. PubMed ID: 180262 [TBL] [Abstract][Full Text] [Related]
6. [Simultaneous detection of IgM antibodies against the hepatitis A virus and the viral capsid antigen of Epstein-Barr virus in acute hepatitis]. Naveau S; Delfraissy JF; Poitrine A; Poynard T; Chaput JC Gastroenterol Clin Biol; 1985 Feb; 9(2):109-12. PubMed ID: 2984075 [TBL] [Abstract][Full Text] [Related]
7. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726 [TBL] [Abstract][Full Text] [Related]
8. [Importance and diagnosis of Epstein-Barr virus infection]. Kuljić-Kapulica N; Krstić L; Budisin A; Kapulica I; Bojić I; Malesević M; Kalinić-Andrić V Vojnosanit Pregl; 1991; 48(4):313-6. PubMed ID: 1660212 [TBL] [Abstract][Full Text] [Related]
14. [Atypical profile problem in serological diagnosis of EBV]. Varıcı Balcı FK; Özbek ÖA; Sayıner AA Mikrobiyol Bul; 2017 Oct; 51(4):378-386. PubMed ID: 29153068 [TBL] [Abstract][Full Text] [Related]
15. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. Obel N; Høier-Madsen M; Kangro H APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671 [TBL] [Abstract][Full Text] [Related]
16. [On the viral etiology of Bell's palsy (An enzyme-linked immunosorbent assay study) (author's transl)]. Mees K; Wolf H; Roggendorf M Laryngol Rhinol Otol (Stuttg); 1981 Dec; 60(12):609-11. PubMed ID: 6285096 [TBL] [Abstract][Full Text] [Related]
17. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
18. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity. Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343 [TBL] [Abstract][Full Text] [Related]
19. Assessment of serologic markers for Epstein-Barr virus. Swanston W; Mahony J; McLaughlin B; Chernesky M Diagn Microbiol Infect Dis; 1986 Sep; 5(3):235-44. PubMed ID: 3019605 [TBL] [Abstract][Full Text] [Related]
20. The seroepidemiology of infection due to Epstein-Barr virus in southern India. Venkitaraman AR; Lenoir GM; John TJ J Med Virol; 1985 Jan; 15(1):11-6. PubMed ID: 2981976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]